Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
In this high-impact “lunch and learn” webinar, our team of expert consultants in Regulatory Advertising and Promotion break down the FDA’s “Clear, Concise, and Neutral” rule (CCN Final Rule) through a series of case studies and evidence-based research.
Presenters:
Kit Aikin, PhD brings 25+ years of FDA experience supporting and leading the Social Science Research Team at OPDP . She has led qualitative and quantitative social and behavioral science research evaluating DTC, DTP, and HCP promotional materials and served as a subject matter expert for regulatory review.
Tim Candy, PharmD brings ~20 years of industry experience with deep expertise in regulatory advertising and promotion. He has extensive hands-on experience in DTC strategy and execution, helping organizations navigate complex promotional requirements while maintaining effectiveness and compliance.
Learning Objectives:
Summarize the most recent violations related to FDA's Clear, Conspicuous, and Neutral (CCN) Rule for presenting the major statement in broadcast TV ads.
Understand what dual modality is (and is not) in the context of the major statement and why this standard is part of the CCN Rule.
Recognize how existing social science research can help identify common violation triggers for visuals that interfere with comprehension of the major statement.
Benefits of Attending:
Learn directly from FDA and industry experts
Gain regulatory authority perspective and real-world application from two highly experienced leaders!
Understand what triggers violations
Learn how visuals can unintentionally interfere with comprehension of the major statement—and how to avoid common pitfalls.
Apply social science to compliance
Discover how existing research can help you proactively identify risk areas and strengthen your promotional review process.
Stay ahead of evolving expectations
With increased scrutiny on DTC TV ads, this session will help you interpret FDA's "Clear, Conspicuous, and Neutral" (CCN) rule.
Practical, actionable takeaways
Walk away with strategies you can immediately apply to reduce regulatory risk and improve communication of the major statement.
This webinar will last approximately 60 minutes and will be held using Zoom.
In this high-impact “lunch and learn” webinar, our team of expert consultants in Regulatory Advertising and Promotion break down the FDA’s “Clear, Concise, and Neutral” rule (CCN Final Rule) through a series of case studies and evidence-based research.
Presenters:
Kit Aikin, PhD brings 25+ years of FDA experience supporting and leading the Social Science Research Team at OPDP . She has led qualitative and quantitative social and behavioral science research evaluating DTC, DTP, and HCP promotional materials and served as a subject matter expert for regulatory review.
Tim Candy, PharmD brings ~20 years of industry experience with deep expertise in regulatory advertising and promotion. He has extensive hands-on experience in DTC strategy and execution, helping organizations navigate complex promotional requirements while maintaining effectiveness and compliance.
Learning Objectives:
Summarize the most recent violations related to FDA's Clear, Conspicuous, and Neutral (CCN) Rule for presenting the major statement in broadcast TV ads.
Understand what dual modality is (and is not) in the context of the major statement and why this standard is part of the CCN Rule.
Recognize how existing social science research can help identify common violation triggers for visuals that interfere with comprehension of the major statement.
Benefits of Attending:
Learn directly from FDA and industry experts
Gain regulatory authority perspective and real-world application from two highly experienced leaders!
Understand what triggers violations
Learn how visuals can unintentionally interfere with comprehension of the major statement—and how to avoid common pitfalls.
Apply social science to compliance
Discover how existing research can help you proactively identify risk areas and strengthen your promotional review process.
Stay ahead of evolving expectations
With increased scrutiny on DTC TV ads, this session will help you interpret FDA's "Clear, Conspicuous, and Neutral" (CCN) rule.
Practical, actionable takeaways
Walk away with strategies you can immediately apply to reduce regulatory risk and improve communication of the major statement.
This webinar will last approximately 60 minutes and will be held using Zoom.